Two coronavirus trials paused over safety concerns
Setback for global efforts to counter Covid as human testing of antibody treatment and vaccine put on hold

Clinical trials of a potential vaccine for Covid-19 and a treatment for people with severe cases of the disease have been put on hold because of separate safety concerns.
The treatment, produced by US drug company Eli Lilly, is “similar to one taken by US President Donald Trump this month”, says the Financial Times. It involves an infusion of “monoclonal antibodies” - artificially produced cells that mimic the human body’s natural immune response to the coronavirus.
“Ambiguity” in Eli Lilly’s statements mean the reason for the pause is unclear, but a trial may be halted if a treatment “has a very low chance of working, based on the data so far” or if “patients in one group are faring much worse than those in the other”, The New York Times reports.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The Eli Lilly announcement came a day after Johnson & Johnson said trials of its coronavirus vaccine were being suspended after a patient in the study fell ill.
The injection is “one of six coronavirus vaccines being tested in the US, and one of four in the most advanced, Phase 3 stage”, reports CNN.
Trials of another vaccine in the final stage of testing, developed by Oxford University and AstraZeneca, were twice put on hold due to unexplained illnesses, but have now resumed in most participating countries.
“In large clinical trials, pauses are not unusual, and declines in health in volunteers are not necessarily the result of the experimental drug or vaccine,” says The New York Times.
“Such halts are meant to allow an independent board of scientific experts to review the data and determine whether the event may have been related to the treatment or occurred by chance.”
Dr Ashish Jha of the Brown University School of Public Health told CNN that delays of this sort were “completely expected” in a trial involving 60,000 people.
Johnson & Johnson said yesterday that its team had not yet established whether the ill patient had received the potential vaccine or a placebo.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Holden Frith is The Week’s digital director. He also makes regular appearances on “The Week Unwrapped”, speaking about subjects as diverse as vaccine development and bionic bomb-sniffing locusts. He joined The Week in 2013, spending five years editing the magazine’s website. Before that, he was deputy digital editor at The Sunday Times. He has also been TheTimes.co.uk’s technology editor and the launch editor of Wired magazine’s UK website. Holden has worked in journalism for nearly two decades, having started his professional career while completing an English literature degree at Cambridge University. He followed that with a master’s degree in journalism from Northwestern University in Chicago. A keen photographer, he also writes travel features whenever he gets the chance.
-
Book reviews: 'Moral Ambition: Stop Wasting Your Talent and Start Making a Difference' and 'Is a River Alive?'
Feature A rallying cry for 'moral ambition' and the interwoven relationship between humans and rivers
-
'King of the Hill' actor shot dead outside home
speed read Jonathan Joss was fatally shot by a neighbor who was 'yelling violent homophobic slurs,' says his husband
-
DOJ, Boulder police outline attacker's confession
speed read Mohamed Sabry Soliman planned the attack for a year and 'wanted them all to die'
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
RFK Jr.: A new plan for sabotaging vaccines
Feature The Health Secretary announced changes to vaccine testing and asks Americans to 'do your own research'
-
Unraveling autism: RFK Jr.'s vow to find a root cause
Feature RFK Jr. has vowed to find the root cause of the 'autism epidemic' in months. Scientists have doubts.
-
The sneaking rise of whooping cough
Under the Radar The measles outbreak isn't the only one to worry about
-
Five years on: How Covid changed everything
Feature We seem to have collectively forgotten Covid’s horrors, but they have completely reshaped politics
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
-
How close are we to a norovirus vaccine?
Today's Big Question A new Moderna trial raises hopes of vanquishing a stomach bug that sickens millions a year